Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
IRVINE, Calif., Oct. 19, 2017 -- Khang & Khang LLP (the “Firm”) announces the filing of a securities class action lawsuit against Navient Corporation (“Navient” or the “Company”) (Nasdaq:NAVI). Investors who purchased or otherwise acquired shares between February 25, 2016 and October 4, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the December 15, 2017 lead plaintiff motion deadline.
If you purchased Navient shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone: (949) 419-3834, or by e-mail at [email protected].
There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.
According to the Complaint, throughout the Class Period, Navient made false and/or misleading statements and/or failed to disclose that: the Company engaged in deceptive practices to facilitate the origination of subprime loans; that the Company committed unfair and deceptive acts by steering student borrowers into payment plans that postponed bills, allowing interest to accumulate, rather than helping them enroll in income-driven repayment plans; and thus, the Company’s public statements were materially false and misleading at all relevant times. When this information was announced, shares of Navient fell in value materially, which caused investors harm according to the Complaint.
If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at [email protected].
This press release may constitute Attorney Advertising in some jurisdictions.
Contact
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
[email protected]
